A label-free nanopore platform uses programmable DNA circuits to build versatile molecular logic gates, forming a universal basis for scalable DNA computing and advanced biosensing applications.

Roche and Boehringer Ingelheim have both formed partnerships with tech companies this week to develop and deploy wearable biosensor technology for use in clinical trials and patient monitoring.

Researchers in the US have developed a prototype of a wearable device that can monitor oestrogen in sweat and could play a role in women’s health and fertility. According to a team from the California ...